Background-Adipose tissue (AT) is the body's largest free cholesterol reservoir and abundantly expresses ATP binding cassette transporter A1 (ABCA1), a key cholesterol transporter for high-density lipoprotein (HDL) biogenesis. However, the extent to which AT ABCA1 expression contributes to HDL biogenesis in vivo is unknown. Methods and Results-Adipocyte-specific ABCA1 knockout mice (ABCA1 ϪA/ϪA ) were generated by crossing ABCA1 floxed mice with aP2 Cre transgenic mice. AT from ABCA1 ϪA/ϪA mice had Ͻ10% of wild-type ABCA1 protein expression but normal hepatic and intestinal expression. Deletion of adipocyte ABCA1 resulted in a significant decrease in plasma HDL cholesterol (Ϸ15%) and apolipoprotein A-I (Ϸ13%) concentrations. AT from ABCA1 ϪA/ϪA mice had a 2-fold increase in free cholesterol content compared with wild-type mice and failed to efflux cholesterol to apolipoprotein A-I. However, cholesterol efflux from AT to plasma HDL was similar for both genotypes of mice. Incubation of wild-type AT explants with apolipoprotein A-I resulted in the formation of multiple discrete-sized nascent HDL particles ranging in diameter from 7.1 to 12 nm; similar incubations with ABCA1 ϪA/ϪA AT explants resulted in nascent HDL Ͻ8 nm. Plasma decay and tissue uptake of wild-type 125 I-HDL tracer were similar in both genotypes of recipient mice, suggesting that adipocyte ABCA1 deficiency reduces plasma HDL concentrations solely by reducing nascent HDL particle formation. Conclusions-We provide in vivo evidence that AT ABCA1-dependent cholesterol efflux and nascent HDL particle formation contribute to systemic HDL biogenesis and that AT ABCA1 expression plays an important role in adipocyte cholesterol homeostasis. (Circulation. 2011;124:1663-1672 .) The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/
A dipose tissue (AT) represents 10% to 35% of total body mass in humans 1 and plays a central role in integrating energy metabolism and glucose homeostasis. 2 Although AT is the major site of fatty acid storage as triglycerides, it is also the body's largest free cholesterol (FC) reservoir. 3 As a result of a lack of acyl-coenzyme A:cholesterol acetyltransferase enzyme activity in AT, nearly all cholesterol (Ͼ95%) exists as FC 4 and resides in the plasma membrane or at the cytosolic interface of lipid droplets. 5 There is accumulating evidence that adipose cholesterol imbalance is closely associated with adipocyte dysfunction and obesity-mediated metabolic complications, including low levels of high-density lipoprotein (HDL) cholesterol and insulin resistance. 6, 7 Therefore, FC efflux from AT is likely to influence whole-body cholesterol metabolism and homeostasis. However, the pathways by which FC exits from AT and its potential impact on plasma HDL cholesterol levels have not been fully investigated.
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ATP-binding cassette transporter A1 (ABCA1) is an essential membrane protein for the initial step of HDL biogenesis by facilitating the efflux of cellular FC and phospholipid to extracellular lipid-free apolipoprotein A-I (apoA-I), forming nascent HDL particles. 8 Loss of function mutations in ABCA1 results in Tangier disease, with Ͻ5% the normal concentration of plasma HDL. 9 Using human embryonic kidney (HEK)-293 cells stably overexpressing ABCA1, we previously demonstrated that ABCA1 expression in a nonhepatic cell line is necessary and sufficient to produce distinct, heterogeneous-sized nascent HDLs, ranging in diameter from 7 to 12 nm, which subsequently undergo intravascular metabolism to become mature HDL in plasma. 10 -12 Although ABCA1 is expressed to various degrees in many different cell types, 13 not all ABCA1-expressing cells contribute equally in vivo to plasma HDL formation. For example, macrophage ABCA1 expression is abundant, but it has no significant impact on plasma HDL levels. 14 On the other hand, hepatic and intestinal ABCA1 expression is estimated to contribute 70% to 80% and 15% to 20% of the plasma HDL pool, respectively. 15, 16 Intriguingly, deletion of both hepatic and intestinal ABCA1 resulted in Ϸ90% reduction in plasma HDL, 16 whereas global ABCA1 knockout (KO) mice have Ͻ5% of normal levels of HDL cholesterol, similar to subjects with Tangier disease. 9 These results suggest that ABCA1 expression in cells other than hepatocytes and intestinal epithelial cells would minimally affect plasma HDL formation. However, formal testing of the contribution of a cell type to the plasma HDL pool requires specific deletion of ABCA1 in that cell.
AT is a major storage pool of FC that expands during obesity and abundantly expresses ABCA1, but the role of adipocyte ABCA1 expression in FC efflux and HDL formation in vivo is unknown. 3, 7, 17 AT has been proposed as being important in plasma HDL production on the basis of indirect evidence such as an inverse association between adipose cholesterol content and plasma cholesterol concentrations. 3 A recent study provided in vivo evidence that adipocytes support the transfer of FC to plasma HDL. 17 In that study, mouse embryonic fibroblasts (from wild-type [WT], ABCA1 KO, and scavenger receptor class B type I [SR-BI] KO mice) were differentiated into adipocytes, radiolabeled with 3 H-cholesterol, and injected into the peritoneal cavity of mice. Reverse cholesterol transport of 3 H-cholesterol from adipocytes to the feces depended on adipocyte expression of ABCA1 and SR-BI. 17 However, direct in vivo evidence for the role of adipose ABCA1 in plasma HDL formation remains lacking, and the extent to which adipose ABCA1 expression contributes to plasma HDL, particularly in the obese state, has not been investigated.
The purpose of this study was to directly test the role of adipocyte ABCA1 in the formation of nascent HDL particles and its contribution to the plasma HDL pool in vivo. To accomplish this, we generated adipocyte-specific ABCA1 KO (ABCA1 ϪA/ϪA ) mice and investigated their plasma lipid and lipoprotein phenotypes during chow and high-fat (HF) diet feeding. We also determined the role of ABCA1 in adipocyte cholesterol homeostasis and nascent HDL particle formation using AT explants from these mice. Our results suggest a significant role for AT ABCA1 expression in nascent HDL particle formation and AT cholesterol homeostasis.
Methods

Animals
Adipocyte-specific ABCA1 KO mice (ABCA1 ϪA/ϪA ) were generated by crossing ABCA1 floxed mice 15 (backcrossed into the Ͼ99% C57BL/6 background) with fatty acid binding protein 4 (aP2) Cre transgenic mice (Jackson Laboratories). For all experiments, 10-to 16-week-old male mice were used. To expand AT mass, mice were switched from a commercial chow diet at 8 weeks of age to a commercial HF diet (42% calories from fat, 0.2% cholesterol; TD 88137, Harlan) for an additional 8 to 16 weeks, depending on the experiment. The mice were housed in the Wake Forest University Health Sciences animal care facilities with a 12-hour light/12-hour dark cycle. All protocols and procedures were approved by the Wake Forest University Health Sciences Animal Care and Use Committee.
Plasma Cholesterol Determination and Fast Protein Liquid Chromatography
Plasma was collected by tail bleeding of mice fasted for 4 hours. Plasma from 4 mice was pooled and size fractionated by fast protein liquid chromatography with a Superose 6 TM column (Amersham Biosciences). Plasma cholesterol was determined with an enzymatic colorimetric assay kit (Roche Applied Science).
Quantitative Polymerase Chain Reaction and Western Blot Analysis
Total RNA was extracted by Trizol (Invitrogen) according to the manufacturer's protocol. cDNA preparation and quantitative polymerase chain reaction were conducted as described previously. 14 To prepare tissue lysate, Ϸ0.1 g snap-frozen tissue was homogenized in radioimmunoprecipitation assay buffer. For AT, the lysate was incubated on ice for 10 minutes to remove the solidified fat cake on top. Immunoblotting of ABCA1 was conducted as previously described with 4% to 16% SDS-PAGE. 15 Monoclonal antibodies directed against PPAR␥ and GAPDH were purchased from Sigma. Polyclonal antibodies against apoE, apoA-I (Biodesign), and anti-SRB-I (Novartis) were also used for Western blotting.
Adipose Cholesterol Determination
AT cholesterol was determined by gas-liquid chromatography after extraction of total lipid from 0.1 g AT with chloroform:methanol (2:1). 14 Data were normalized to tissue wet weight or protein, measured by the Lowry assay. 18
Preparation of Ex Vivo Cultures of AT
To establish the ex vivo cultures of AT, freshly isolated epididymal fat (0.1-Ϸ0.2 g) was minced into Ϸ2-mm pieces, moved into 10-cm cell culture dishes, and incubated overnight in 1.5 mL serum-free Dulbecco Modified Eagles Medium F/12 Ham (Santa Cruz). The next day, AT cultures were washed thoroughly with caution to remove floating cells without aspirating the minced tissue explants.
Cholesterol Efflux From AT
Measurement of cholesterol efflux was conducted according to standard methods, except ex vivo AT cultures were used. 17, 19 Briefly, ex vivo cultures of AT (pooled from nϭ4 mice per genotype; nϭ4 replicates) were incubated with 5 Ci of [ 3 H]-cholesterol (complexed to bovine serum albumin) for 24 hours. AT explants were then washed carefully, and 1 mL fresh serum-free medium was added. Cholesterol efflux was initiated by adding either 20 g protein/mL of human apoA-I (ABCA1-dependent efflux) or 50 g protein/mL mouse HDL (ABCA1-independent efflux) as acceptors. After 4 hours of additional incubation, cholesterol efflux was quantified by measuring [ 3 H]-cholesterol in 500 L medium and in the cells after isopropanol extraction. Percentage efflux was calculated as follows: dpm [ 3 H]-cholesterol in medium/dpm [ 3 H]-cholesterol (mediumϩcells)ϫ100%.
Nascent HDL Formation
All the procedures for nascent HDL formation were similar to our previous study. 20 Briefly, 10 g/mL lipid-free [ 125 I]-apoA-I (10 5 cpm/g) was incubated with AT explants for 24 hours. Conditioned medium (1 mL) was then fractionated by high-resolution fast protein liquid chromatography size-exclusion chromatography with 3 Superdex 200 HR columns in series. 125 I radioactivity in each fraction was quantified with a gamma counter (Beckman). Electrophoretic mobility of adipose-derived nascent HDLs was analyzed with a Paragon lipoprotein agarose gel electrophoresis system (Beckman) according to the manufacturer's instructions. Electrophoretic mobilities (␣, ␤, pre-␤) were determined after lipid staining of plasma from low-density lipoprotein receptor KO mice. The size distribution of nascent HDL particles in conditioned medium was also deter-mined on a 4% to 30% nondenaturing gradient gel as described previously. 20 HDL Catabolism and Tissue-Specific Uptake 125 I-radiolabeled tyramine cellobiose (TC)-HDL ([ 125 I]-TC-HDL) was prepared as previously described, except HDL was isolated from WT mouse plasma. 15, 21 Recipient mice (nϭ4 per genotype) were anesthetized with isoflurane, and [ 125 I]-TC-HDL (500 000 cpm/ animal) was injected via a jugular vein catheter. Blood samples (Ϸ30 L) were drawn at 5 minutes, 30 minutes, and 1, 3, 6 and 24 hours after tracer injection by retro-orbital bleeding, and 15 L plasma was used for quantification of [ 125 I] radioactivity. Data were expressed as a percentage of the 5-minute plasma radioactivity remaining in plasma after injection of the tracer. The plasma die-away curves were generated with a biexponential curve-fitting program (Graph-Pad Prism 5; San Diego, CA). For the determination of tissuespecific uptake of HDL, mice were euthanized 24 hours after [ 125 I]-TC-HDL injection, and liver, kidney, and epididymal fat pads were removed to quantify 125 I radioactivity.
Statistics
Results are presented as meanϮSEM. Data were analyzed statistically by the use of multiple tests. A general linear regression model was used to assess relationships between FC and ABCA1 within and across fat depots while controlling for intra-animal correlations. A Student t test was used to test for differences in AT ABCA1 expression and radiolabeled HDL tracer tissue uptake between WT and ABCA1 ϪA/ϪA mice. For comparison of variables (ie, total plasma cholesterol, epididymal fat cholesterol content) among all 3 genotypes of mice or Ͼ2 treatments (cholesterol efflux), 1-way ANOVA, followed by the Tukey multiple comparison test to identify individual group differences, was used. Two-way ANOVA with repeat measures (time course, 0 -16 weeks) was used to compare total plasma cholesterol concentrations during HF diet feeding between WT and ABCA1 ϪA/ϪA mice. Statistical tests were performed with GraphPad software or SAS software.
Results
ABCA1 Expression Varies Among Fat Depots
AT exhibits regional heterogeneity with regard to cellular composition, response to hormonal signals, and metabolic function. 22 To gain insight into the role of fat depot-specific cholesterol regulation by ABCA1, C57BL/6 mice (nϭ3) were fed an HF (HF/high-cholesterol) diet (42% fat and 0.2% cholesterol) to increase fat mass. After the mice had consumed the diet for 8 weeks, we measured cholesterol content by gas-liquid chromatography and relative ABCA1 expression by Western blot in different fat depots. There was a 6-fold variation in FC content (no detectable cholesteryl ester) among fat depots (epididymalϾmesentericϾpericardialϷinguinal (subcutaneous)Ͼ brown fat). ABCA1 expression was equally variable among depots, with a strongly positive correlation (r 2 ϭ0.34, Pϭ0.01) between fat depot FC content and ABCA1 expression, but not SR-BI or apoE expression ( Figure 1A and 1B).
Next, we examined AT ABCA1 expression using epididymal fat depots from C57BL/6 mice. There are conflicting results in the literature on the extent to which 3T3-L1 fibroblasts express ABCA1 before they are differentiated into adipocytes. 17, 19 To determine whether ABCA1 is expressed in nonadipocyte cells residing in AT, stromal vascular cells were fractionated from floating mature adipocytes with the use of previously described methods. 23 ABCA1 expression was almost exclusively confined to adipocytes, with little expression in stromal vascular cells (online-only Data Sup-plement). To establish a primary adipocyte culture system from mouse AT, isolated stromal vascular cells were incubated with a differentiation cocktail. 23 After 10 days, Ϸ60% of cells were converted into lipid-laden adipocytes by Oil Red O staining ( Figure IA in the online-only Data Supplement). ABCA1 expression levels were also increased during adipogenesis ( Figure 1D ). To determine the cellular localization of ABCA1, adipocyte cultures were immunostained with ABCA1 monoclonal antibody. ABCA1 staining was observed in the plasma membrane and cytosol of adipocytes, suggesting that ABCA1 may traffic between the plasma membrane and cytosol ( Figure IB in the online-only Data Supplement).
AT Generates Nascent HDL Particles of Multiple Sizes
ABCA1-dependent FC efflux has been reported for 3T3-L1 adipocytes 19, 24 and mouse embryonic fibroblast-derived adipocytes. 17 However, ABCA1-dependent nascent HDL particle formation by unilocular adipocytes in AT has not been investigated. Thus, we established ex vivo cultures of mouse epididymal AT and incubated the freshly isolated AT explants with [ 125 I]-apoA-I for 24 hours, after which nascent HDL subpopulations in the conditioned medium were size fractionated by high-resolution fast protein liquid chromatography. 10, 11 Consistent with our previous studies using HEK293 cells stably expressing human ABCA1, 10, 11 AT from C57BL/6 mice generated heterogeneously sized nascent HDL particles that migrated in the pre-␤ position on agarose gels ( Figure 1E ). More important, the size distribution of nascent HDL species from AT followed a pattern similar to that from HEK293-ABCA1-expressing cells ( Figure 1F ) and mouse peritoneal macrophages and McArdle 7777 hepatoma cells, 11 with 5 distinct subfractions ranging in size from 7 to 17 nm in diameter.
Deletion of Adipocyte ABCA1 Decreases Plasma HDL Levels
To investigate the role of adipocyte ABCA1 in AT cholesterol mobilization and its impact on HDL plasma level in vivo, we generated adipocyte-specific ABCA1 KO mice (ABCA1 ϪA/ϪA ). Adipocyte-specific ABCA1 inactivation was achieved by crossing C57BL/6 ABCA1 flox/flox mice with aP2 (fatty acid binding protein 4)-Cre transgenic mice backcrossed in the C57BL/6 background (Jackson Laboratories). ABCA1 ϪA/ϪA mice were fertile, and pups were born at the expected mendelian frequency. Recombination of the floxed ABCA1 allele resulted in a Ͼ90% decrease in ABCA1 protein expression in ABCA1 ϪA/ϪA mouse epididymal fat and 87% reduction of ABCA1 mRNA in epididymal fat (Figure 2A ). Inactivation of adipose ABCA1 had little effect on ABCA1 expression in liver and intestine, which are the main organs known to be important for HDL biogenesis ( Figure 2B ). However, ABCA1 expression was noticeably reduced in resident peritoneal macrophages ( Figure 2C ), thioglycolate-elicited macrophages ( Figure 2D) , and, to a lesser extent, in bone marrow-derived macrophages ( Figure  2C ). ABCA1 expression in WT epididymal and mesenteric AT was abundant and comparable to that in liver and macrophages, but its expression was markedly blunted in ABCA1 ϪA/ϪA mouse epididymal, brown, and mesenteric fat ( Figure 2D ). Thus, deletion of ABCA1 expression was highly efficient in AT and somewhat variable in macrophages. However, macrophage ABCA1 expression has minimal impact on plasma HDL levels, 14, [25] [26] [27] so we proceeded with studies on the role of adipocyte ABCA1 expression on HDL metabolism and adipocyte cholesterol balance.
Next, we evaluated the contribution of adipose ABCA1 expression on plasma cholesterol concentrations and distribution using WT and ABCA1 ϪA/ϪA mice consuming chow or an HF diet. There was a stepwise reduction in total plasma cholesterol with successive deletion of ABCA1 alleles (WT, 83Ϯ3 mg/dL; heterozygotes, 70Ϯ6 mg/dL; homozygotes, 62Ϯ4 mg/dL; Figure 3A ) that reached statistical significance for male WT versus ABCA1 ϪA/ϪA mice (PϽ0.0084 by ANOVA with the Tukey post hoc test). In addition, Western blot analysis of plasma suggested a reduction in apoA-I (KO/WT ratioϭ0.72) and apoE (KO/WT ratioϭ0.86) concentration but not lecithin-cholesterol acyltransferase (KO/WT ratioϭ1.03) ( Figure 3B ). The lower plasma cholesterol levels for ABCA1 ϪA/ϪA mice persisted throughout the 16 weeks of HF diet (2-way ANOVA with repeated mea- GAPDH was used as a load control. B, Association between ABCA1 expression and free cholesterol (FC) content among 6 fat depots in C57BL/6 mice fed an HF diet for 8 weeks (nϭ3 mice for each depot). Across depots, the line of best fit (r 2 ϭ0.34), determined by regression analysis for all data points controlling for intra-animal correlations, is shown (PϽ0.01). Within depots, the overall association did not reach statistical significance owing to 1 outlier value in retrorenal fat. C, ABCA1 expression in adipose tissue (AT), adipocytes (Adi), and stromal vascular (SV) cells. Collagenase-treated epididymal fat was fractionated into floating adipocytes and pelleted stromal vascular cells for Western blot analysis of ABCA1 and aP2 expression. ␤-Actin was used as a load control. D, ABCA1 expression at 0, 3, and 10 days after differentiation of SV cells into adipocytes. sures; time effect, PϽ0.0001; genotype effect, PϽ0.001; nϭ4 each), suggesting that deletion of adipose ABCA1 results in decreased plasma cholesterol pool size despite expanding AT mass ( Figure 3C ). Fast protein liquid chromatography fractionation of plasma revealed that the decreased plasma cholesterol in ABCA1 ϪA/ϪA mice was mainly in the HDL region of the column ( Figure 3D ). These data provide evidence that AT ABCA1 expression contributes a small but significant fraction of the plasma HDL pool.
To exclude the possibility that decreased plasma HDL concentration in ABCA1 ϪA/ϪA mice was due to increased hepatic uptake and degradation of HDL, we measured plasma clearance and tissue uptake of HDL apoA-I. Because HDL from WT and ABCA1 ϪA/ϪA mice was similar in chemical composition (data not shown), HDL was isolated from plasma of WT mice and radiolabeled with TC, a tissue residualizing compound that allows quantification of tissue uptake of radiolabeled tracer during turnover studies. 15, 21 The plasma removal of [ 125 I]-TC-HDL tracer in ABCA1 ϪA/ϪA mice was indistinguishable from that of WT mice over the 24-hour turnover study ( Figure 4A ). There also was no difference in tissue uptake of HDL tracer by liver, kidney, or AT ( Figure 4B ), indicating that selective inactivation of adipocyte ABCA1 did not affect HDL catabolism in vivo. These results suggested that the decreased plasma HDL levels in ABCA1 ϪA/ϪA mice were due to decreased HDL production by AT.
Deletion of Adipocyte ABCA1 Blunted ABCA1-Dependent Cholesterol Efflux and Large Nascent HDL Formation in AT
To determine whether deletion of ABCA1 in adipocytes resulted in increased FC content, similar to what we observed in macrophages from macrophage-specific ABCA1 KO mice, 14 we measured TC and FC in epididymal and brown fat from 3 to 4 mice after 16 weeks of HF/high-cholesterol diet feeding. There was a gene dose-related increase in FC content (PϽ0.001) in epididymal fat that reached statistical significance in ABCA1 ϪA/ϪA mice ( Figure 5A ). Cholesteryl ester was low to undetectable in the samples (data not shown). These results suggested that FC efflux from adipose explants was severely compromised in the absence of functional ABCA1. To address this question, we incubated AT explants from chow-fed mice with 3 H-cholesterol for 24 hours to radiolabel the cells, washed the cells, and incubated them for 4 hours with apoA-I (20 g/mL) to measure ABCA1dependent efflux or with HDL (50 g/mL) to measure ABCA1-independent efflux. ABCA1-dependent 3 H-FC efflux to apoA-I was completely eliminated in ABCA1 ϪA/ϪA epididymal fat compared with WT. However, HDL-mediated FC efflux (ABCA1 independent) was unaffected by deletion of adipose ABCA1 expression ( Figure 5B ). To determine whether the ablation of ABCA1-dependent efflux to apoA-I in ABCA1 ϪA/ϪA epididymal fat was accompanied by loss of Figure 5C ). WT epididymal fat generated multiple, heterogeneous-sized HDL subfractions that ranged in size from 7 to 12 nm in diameter, which we have designated pre-␤ 1 to 5 in order of increasing particle size. We have also observed similar nascent HDL particle size heterogeneity in cultures of HEK293 cells stably expressing ABCA1, mouse peritoneal macrophages, and rat McArdle 7777 hepatoma cells. 11, 20 In contrast, epididymal fat from ABCA1 ϪA/ϪA mice generated only particles Ͻ10 nm in diameter (ie, pre-␤ 2).
Discussion
This study was designed to elucidate the role of adipocyte ABCA1 expression in nascent HDL particle formation and its contribution to the plasma HDL pool in vivo. To address this issue, we generated ABCA1 ϪA/ϪA mice and studied them while they were consuming a chow or HF diet. Several novel observations were made in this study. First, AT ABCA1 expression varied over a 5-fold range among different fat depots in C57BL/6 mice and was significantly associated with FC content among different ATs, suggesting an important role for ABCA1 expression in AT sterol homeostasis. Second, ABCA1 ϪA/ϪA mice had Ͻ10% expression of ABCA1 protein in AT compared with WT mice, with a concomitant 2-fold increase in AT cholesterol content. Although FC efflux from AT explants to HDL was similar between WT and ABCA1 ϪA/ϪA mice, FC efflux to apoA-I was eliminated in ABCA1 ϪA/ϪA AT, suggesting an important and specific role for ABCA1 in AT FC homeostasis. Third, WT AT explants were capable of generating multiple, discrete-sized nascent HDL subfractions from apoA-I, ranging in diameter from 7 to 12 nm, similar to other cell types. However, ABCA1 ϪA/ϪA AT generated nascent HDL particles Ͻ10 nm, suggesting a considerable loss of function in the ability to generate nascent HDL. The decreased ability to generate nascent HDL was reflected in vivo as a 15% reduction in plasma HDL concentration in ABCA1 ϪA/ϪA versus WT mice that was attributed to HDL production because HDL catabolism was similar between the 2 genotypes of mice. Collectively, these results establish a novel role for adipocyte ABCA1 in AT cholesterol mobilization and cholesterol balance and in vivo HDL production.
AT, the main depot for triglycerides, is used to meet systemic energy needs. 3 It is also the body's largest cholesterol storage depot; uniquely, Ͼ95% of AT cholesterol is FC as a result of low esterification activity by acyl-coenzyme A:cholesterol acetyltransferase. 3 As adipocytes expand in size during obesity, FC and lipid droplet FC increase, 3 but plasma membrane FC decreases. 28 This redistribution of FC increases plasma membrane fluidity, decreases insulin signaling, and increases adipocyte cholesterol biosynthesis. 28 Thus, maintaining the optimal amount and intracellular distribution of FC in adipocytes appears functionally important in AT. Because cholesterol biosynthesis is relatively low in AT, 29 FC efflux may be an important regulator of sterol homeostasis. Recent studies indicate that ABCA1 and SR-BI are important regulators of cholesterol efflux from adipocytes. 17 Initially, adipocytes were thought to have low ABCA1 expression, 13 but subsequent studies using 3T3L1 adipocytes 17, 28 and AT 30 and our data in isolated adipocytes ( Figure 1C and 1D) demonstrate that ABCA1 is abundantly expressed. Furthermore, we observed that ABCA1 expression varies over a 5-fold range among AT depots and that this variation is highly correlated with AT FC content ( Figure 1A and 1B) . These data suggest that as metabolically active visceral fat stores enlarge during TG accretion, FC also increases; this in turn upregulates expression of ABCA1 to rebalance cellular cholesterol homeostasis. ABCA1 gene transcription is highly regulated by liver X receptor expression in some tissues, 31, 32 but whether this pathway is responsible for variable ABCA1 protein expression among AT depot sites is unknown. Nevertheless, these data establish a critical association between AT ABCA1 expression and FC content, which may be important in the modulation of adipocyte metabolic activity.
To determine the role of AT ABCA1 expression in plasma HDL concentrations, we generated ABCA1 ϪA/ϪA mice by crossing ABCA1 flox/flox mice with aP2 Cre recombinase transgenic mice. ABCA1 protein expression in epididymal fat decreased in proportion to the number of inactivated ABCA1 alleles ( Figure 1A) . Recombination of the ABCA1 gene was efficient in all AT depots examined, with Ͼ90% elimination of ABCA1 protein expression in ABCA1 ϪA/ϪA mice. Expression of SR-BI, another protein important in adipocyte FC efflux, 17 was unaffected ( Figure 1D ). ABCA1 ϪA/ϪA mice had lower plasma total and HDL cholesterol concentrations compared with WT mice, whether they were fed chow or an HF diet ( Figure 3C and 3D). To determine whether this phenotype was due directly to deletion of AT ABCA1 or indirectly to changes in ABCA1 expression in other tissues, the specificity of the recombination was investigated. ABCA1 expression in liver and intestine, 2 tissues previously shown to be important in determining plasma HDL concentrations, 15, 16 was similar in WT and ABCA1 ϪA/ϪA mice and could not account for the differences in plasma HDL concentrations. aP2 Cre recombinase has been reported to be active in macrophages, 33 so we also examined ABCA1 expression in resident, elicited peritoneal, and bone marrow-derived macrophages. ABCA1 expression was variably reduced in macrophages from ABCA1 ϪA/ϪA mice, confirming previous results that aP2 Cre recombinase was active in macrophages. 34 However, evidence from our laboratory 14 and others [25] [26] [27] using transplantation of total ABCA1 KO bone marrow has demonstrated that macrophage ABCA1 expression has no significant impact on plasma HDL concentrations. Taken together, these data suggest that AT ABCA1 expression plays a significant role in determining plasma HDL concentrations.
Although our data suggested that HDL production by AT was reduced in the absence of adipocyte ABCA1 expression, deletion of adipocyte ABCA1 may have indirectly increased HDL catabolism, resulting in reduced plasma HDL levels. Previous studies in humans suggest that HDL catabolism plays an important role in determining plasma HDL concentrations. 35 To formally examine this possibility, we performed HDL turnover studies using radiolabeled WT HDL because HDL composition was similar between WT and ABCA1 ϪA/ϪA mice (data not shown). Plasma decay of the HDL tracer and uptake of radiolabel by the liver and kidney, the 2 most important tissues in HDL protein uptake and catabolism, 15, 21 were similar for both genotypes of mice ( Figure 4 ). From these data, we conclude that decreased plasma HDL concentrations in ABCA1 ϪA/ϪA mice were due to decreased HDL production by AT relative to WT mice and not to differences in HDL catabolism.
Although our study and others 17 implicate AT in HDL production, direct evidence for the assembly of nascent HDL particles by AT has not been demonstrated. In this study, we show that epididymal fat from ABCA1 ϪA/ϪA mice had a doubling of FC content, was defective in FC efflux to apoA-I, and was defective in the production of nascent HDL particles Ͼ10 nm in diameter ( Figure 5 ). Zhang et al 17 have shown that both ABCA1 and SR-BI, but not ABCG1, are important for FC efflux from adipocytes, differentiated from mouse embryonic fibroblasts. Our study confirms and extends their results by showing that ABCA1 is critical for maintaining FC content and efflux to ABCA1 in primary AT explants. Furthermore, the 2-fold increase in AT FC content suggests that SR-BI cannot compensate for the loss of ABCA1 expression. This was confirmed by the similar expression of SR-BI among AT depots in WT and ABCA1 ϪA/ϪA mice ( Figure 2D ). Previous studies have shown that ectopic expression of ABCA1 in cell lines is necessary and sufficient to A, HDL isolated from wild-type (WT) mice was radiolabeled with 125 I-tyramine cellobiose (TC) and injected into the jugular vein of ϩ/ϩ (WT; nϭ4) and ϪA/ϪA (ABCA1 ϪA/ϪA ; nϭ4) recipient mice. Periodic blood samples over a 24-hour time period after injection were withdrawn to quantify the radioactivity remaining in plasma, normalized to percentage of injected tracer. B, Twenty-four hours after 125 I-TC-HDL tracer injection, mice were euthanized and liver, kidney, and epididymal fat (adipose) were removed to quantify tracer uptake by each organ. Data were normalized to liver uptake in WT mice.
generate several discrete-sized nascent HDL particles. 10 We have designated these particles pre-␤ 1 to 5 on the basis of increasing particle size on nondenaturing gradient gels and fast protein liquid chromatography columns and mobility on agarose or 2-dimensional gels. These nascent pre-␤ HDL particles appear to be formed simultaneously in cell culture systems, with no evidence for a precursor-product dependency (ie, small particles3larger particles). 10,36 -38 Similar discrete, nascent HDL particle sizes have previously been observed for McArdle 7777 hepatoma cells, mouse peritoneal macrophages, 11 and primary hepatocytes (unpublished data), in addition to transfected cell lines, suggesting that ABCA1 expression is the necessary and sufficient condition for nascent HDL size heterogeneity among these varied cell types. Epididymal fat explants from WT mice also generated nascent HDL particles with apoA-I that were strikingly similar in size to those reported for other cell culture systems ( Figure 1F ). However, epididymal fat explants from ABCA1 ϪA/ϪA mice did not generate nascent HDL Ͼ10 nm ( Figure 5C ). We speculate that the formation of pre-␤ 2 HDL resulted from the residual (Ͻ10%) ABCA1 protein expression in AT of ABCA1 ϪA/ϪA mice ( Figure 2D ). Support for this idea comes from a study in which siRNA silencing of ABCA1 in McArdle 7777 hepatoma cells resulted in Ϸ70% to 80% reduction of ABCA1 protein expression and decreased formation of nascent HDL Ͼ10 nm. 20 Overall, our studies provide evidence that AT ABCA1 expression directly contributes to the formation of multiple, discrete-sized nascent HDL particles.
Obesity is associated with chronic low-grade inflammation, adipocyte dysfunction (ie, adipokine secretion, impaired lipolysis, insulin resistance), and low plasma HDL. 39 Adipocyte ABCA1 expression may represent a compensatory mechanism to limit inflammation and adipocyte dysfunction that accompanies obesity and metabolic syndrome. Because adipocyte FC content increases with obesity and adipocyte hypertrophy, we speculate that ABCA1 is upregulated in adipocytes to maintain optimal FC balance between the lipid droplet and plasma membrane and adipocyte function. With development of obesity, accretion of FC during adipocyte expansion may sequester FC on lipid droplets, shunting it away from ABCA1-mediated HDL particle formation, resulting in decreased plasma HDL concentrations. In contrast, rapid weight loss may result in FC mobilization to the adipocyte plasma membrane, resulting in increased ABCA1mediated HDL particle formation and increased plasma HDL concentrations. Thus, adipocyte ABCA1 may be a critical negative regulator of obesity and metabolic syndrome, preventing adipocyte dysfunction and abnormal plasma membrane FC accumulation by facilitating FC efflux and nascent HDL formation.
